Stock Events

Stock Events

Amylyx Pharmaceuticals (AMLX) Q3 2025 Earnings

7AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-1.07

-0.85

-0.64

-0.42

Details

Expected EPS

-0.444426

Actual EPS

-0.46

Surprise EPS

-0.02

Surprise Percent

+3.5%

Description

Amylyx Pharmaceuticals (AMLX) has reported earnings of -0.46 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.